Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 7, 2015Virtual Press Office and PR Newswire: General Trade show news
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the Oppenheimer 26th Annual Healthcare Conference on Tuesday, December 8, 2015 at 9:45 a.m....
-
Dec 7, 2015Virtual Press Office and PR Newswire: General Trade show news
DuPont Fabros Technology, Inc. (NYSE: DFT), a leading owner, developer, operator and manager of enterprise-class, carrier-neutral, large multi-tenant wholesale data centers, today announced that...
-
Dec 7, 2015Virtual Press Office and PR Newswire: General Trade show news
Paragon Offshore plc ("Paragon") (NYSE: PGN) announced today that Lee M. Ahlstrom, Senior Vice President – Investor Relations, Strategy and Planning of Paragon, will present at the Capital One...
-
Dec 7, 2015Virtual Press Office and PR Newswire: General Trade show news
Klas Telecom demonstrated a strong multipresence at this year's largest-ever U.S. Army Network Integration Evaluation (NIE) 16.1, where the company's products and services supported three...
-
Dec 7, 2015Virtual Press Office and PR Newswire: General Trade show news
The 2016 Expo Light Shanghai will be an important theme at the Shanghai Hospitality Design & Engineering Exposition, which will be held at the Shanghai New International Expo Center from March 29...
-
Dec 6, 2015Virtual Press Office and PR Newswire: General Trade show news
Value investment firm Brandes Investment Partners, L.P., announced today that Charles Brandes, CFA, will present at the inaugural Asia Value Investor Conference in Hong Kong on December 8, 2015....
-
Dec 6, 2015Virtual Press Office and PR Newswire: General Trade show news
Today, AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced preliminary data from the ongoing Phase 1/2b PCYC-1119 trial suggesting that the combination of ibrutinib (IMBRUVICA®)...
-
Dec 6, 2015Virtual Press Office and PR Newswire: General Trade show news
CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced an update on results from an investigator-sponsored Phase 2 trial of tosedostat – the company's investigational oral...
-
Dec 6, 2015Virtual Press Office and PR Newswire: General Trade show news
AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced results of a Phase 2, open label trial studying investigational compound venetoclax in patients with relapsed/refractory...
-
Dec 6, 2015Virtual Press Office and PR Newswire: General Trade show news
Data from the investigational, randomized, multi-center, open-label Phase 3 RESONATE™-2 (PCYC-1115) clinical trial show ibrutinib (IMBRUVICA®) was superior to chlorambucil in all efficacy...